Concepedia

Catherine E. Fitzgerald

CE

Statistics

Publications

14

Citations

632

H-Index

12

Active since

1996

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Kansas City University

Stratford University

Catherine E. Fitzgerald is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, enzyme inhibition, and medicinal chemistry.

Publications per year

1996–2012

14

Publications

14

Structural basis for p38α MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity

Catherine E. Fitzgerald, Sangita B. Patel, Joseph W. Becker et al. · Nature Structural & Molecular Biology · 2003 · 182 citations · Full text

, , +15

c-Src Is Required for Stimulation of Gelsolin-associated Phosphatidylinositol 3-Kinase

Meenakshi A. Chellaiah, Catherine E. Fitzgerald, Ulises Alvarez et al. · Journal of Biological Chemistry · 1998 · 98 citations · Full text

, , +17

Chemical Genetics Define the Roles of p38α and p38β in Acute and Chronic Inflammation

Stephen J. O’Keefe, John S. Mudgett, Susan Cupo et al. · Journal of Biological Chemistry · 2007 · 80 citations · Full text

, , +17

Osteopontin activation of c-src in human melanoma cells requires the cytoplasmic domain of the integrin alpha v-subunit.

Meena Chellaiah, Catherine E. Fitzgerald, Edward J. Filardo et al. · Endocrinology · 1996 · 53 citations

, , +12

Hybrid-Designed Inhibitors of p38 MAP Kinase Utilizing<i>N</i>-Arylpyridazinones

Steven L. Colletti, Jessica L. Frie, Elizabeth C. Dixon et al. · Journal of Medicinal Chemistry · 2002 · 42 citations · Full text

, , +16

1–5 of 14